STUDIES IN POSTMORTEM BACTERIOLOGY .1. NECROPSY STERILITY IN 3 PATIENTS AS LONG AS 35 DAYS POSTMORTEM

被引:0
|
作者
NEHRING, JR
SHERIDAN, MF
FUNK, WF
ALDERSON, GL
机构
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:12 / &
相关论文
共 41 条
  • [31] Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)
    Lebwohl, Mark G.
    Leonardi, Craig L.
    Mehta, Nehal N.
    Gottlieb, Alice B.
    Mendelsohn, Alan M.
    Parno, Jeff
    Rozzo, Stephen J.
    Menter, M. Alan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (02) : 398 - 407
  • [32] Risankizumab (RZB) Demonstrates Long-Term Efficacy Across Subgroups in Patients with Active Psoriatic Arthritis (PsA): A Post Hoc, Integrated Analysis from the Phase 3 (KEEPsAKE 1 and KEEPsAKE 2) Studies
    Merola, Joseph
    Callis-Duffin, Kristina
    Padilla, Byron
    Yue, Cuiyong
    Photowala, Huzefa
    Kaplan, Blair
    McInnes, Iain B.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 602 - 603
  • [33] ACTIVE HEPATITIS-B IMMUNIZATION WITH AN EXPERIMENTAL GERMAN VACCINE .1. IMMUNOGENICITY STUDIES IN HEALTHY-ADULTS .2. THE PRIMARY 19S AND 7S RESPONSES TO HBSAG IN HEALTHY-ADULTS .3. IMMUNOGENICITY STUDIES IN HEMODIALYSIS-PATIENTS
    SCHEIERMANN, N
    KUWERT, EK
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1984, 257 (03): : 439 - 455
  • [34] Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies
    Molina, Jean Michel
    Ene, Luminita
    Cahn, Pedro
    Faetkenheuer, Gerd
    Van Wijngaerden, Eric
    Lombaard, Johan
    Zakharova, Natalia
    Van Eygen, Veerle
    Vanveggel, Simon
    Van Solingen-Ristea, Rodica
    ANTIVIRAL THERAPY, 2021, 26 (6-8) : 95 - 105
  • [35] Long-term safety and efficacy of rilpivirine plus nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 7-year roll-over study from phase 2 and 3 clinical studies
    Molina, J-M
    Faetkenheuer, G.
    Van Wijngaerden, E.
    Cahn, P.
    Ene, L.
    Lombaard, J.
    Zakharova, N.
    Van Eygen, V.
    Vanveggel, S.
    Van Solingen-Ristea, R.
    HIV MEDICINE, 2019, 20 : 96 - 96
  • [36] Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
    Gisondi, Paolo
    Gottlieb, Alice B. B.
    Elewski, Boni
    Augustin, Matthias
    McBride, Sandy
    Tsai, Tsen-Fang
    de la Loge, Christine
    Fierens, Frederik
    Lopez Pinto, Jose M.
    Tilt, Nicola
    Lebwohl, Mark
    DERMATOLOGY AND THERAPY, 2023, 13 (01) : 315 - 328
  • [37] Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
    Paolo Gisondi
    Alice B. Gottlieb
    Boni Elewski
    Matthias Augustin
    Sandy McBride
    Tsen-Fang Tsai
    Christine de la Loge
    Frederik Fierens
    José M. López Pinto
    Nicola Tilt
    Mark Lebwohl
    Dermatology and Therapy, 2023, 13 : 1389 - 1390
  • [38] Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (vol 13, pg 315, 2023)
    Gisondi, Paolo
    Gottlieb, Alice B.
    Elewski, Boni
    Augustin, Matthias
    McBride, Sandy
    Tsai, Tsen-Fang
    de la Loge, Christine
    Fierens, Frederik
    Lopez Pinto, Jose M.
    Tilt, Nicola
    Lebwohl, Mark
    DERMATOLOGY AND THERAPY, 2023, 13 (06) : 1389 - 1390
  • [39] TWO PHASE 3, LONG-TERM STUDIES OF ESKETAMINE NASAL SPRAY PLUS ORAL ANTIDEPRESSANT IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION: SUSTAIN-1 (RANDOMIZED, WITHDRAWAL, DOUBLE-BLIND, RELAPSE PREVENTION STUDY) AND SUSTAIN-2 (OPEN-LABEL, SAFETY AND EFFICACY STUDY)
    Singh, J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 106
  • [40] OBSERVATIONS ON THE VASODILATOR PROPERTIES OF URINE .1. COMPARISON OF THE EFFECT OF HUMAN URINE AND NITROGLYCERIN ON CORONARY RESISTANCE AND MYOCARDIAL OXYGEN CONSUMPTION IN THE ISOLATED SUPPORTED HEART PREPARATION .2. THE PROBLEM OF REPRODUCIBILITY IN BLOOD FLOW BIOASSAY TECHNICS FOR VASOACTIVE SUBSTANCES - STUDIES WITH HUMAN URINE .3. COMPARISON OF VASODILATOR ACTIVITY IN THE URINE OF NORMAL INDIVIDUALS AND PATIENTS WITH ORTHOSTATIC HYPOTENSION
    SARNOFF, SJ
    CASE, RB
    MACRUZ, R
    SARNOFF, LC
    SUSSMAN, KE
    SARNOFF, SJ
    SUSSMAN, KE
    PIERCE, JV
    SARNOFF, LC
    CIRCULATION RESEARCH, 1958, 6 (04) : 522 - 537